The crucial changes have taken place in the role of pharmacy profession in the past decade. All these changes have been systematically evolved and adopted to support professional quality improvement aspect. In general, the worldwide professional and national authorities have been committed to develop the professional competencies, credentialing and continuing professional development; to emphasis the maintenance of high standards of professional development and in response to changes which occurred to pharmacy education and national health regulation policy. The constantly evolving health regulatory environment in each country will shape the progress of this process in the future.
Introduction
Drug therapy is the most frequently used form of treatment in any health practice setting. Namely, evidencebased practices confirm that drug therapy treatment has significantly increased due to the aging of world population, emerging of new infectious diseases, the prevalence of chronic diseases and increased number of patients who suffer from co-morbidities and require implementation of advanced multidrug therapy approach of complex nature (Kaplan and Laing, 2004) . It must also be taken into account that community-based treatments for both acute and chronic illnesses that include newly developed therapies and act as the driving force towards outpatient surgeries have been related with the increased need of use of drugs. Moreover, with the development of the drug science and state-of-the art industrial technologies, the range of new efficient drugs has dramatically expanded. It is also worth to mention that the adoption and implementation of new health technologies created real opportunities for increased access to drugs. On the other hand, health technologies also alter the way of receiving health services and ultimately revolutionize healthcare operations. Nowadays, modern health facilities apply computerized dispensing techniques and devices. Since recently, drugs can also be obtained by mail order and via Internet. As far as the drugs are concerned, the increased number of prescriptions, and the increased number of available over-the-counter drugs (Fenichel, 2004) , as a consequence focused the patient interest on self-directed care. The complexity of these features, as noted above, combined with these new circumstances have placed the pharmacist in a more prominent position in terms of providing more information and sophisticated services to patients. The new role of pharmacists requires improved platform of knowledge, skills, eth-ical attitude, and behavior that would contribute to the development of competently trained and adequately credentialed professionals.
The objective of this general overview is to present the first initiative of competency and categories of credentialing of pharmacy professionals, continual education of pharmacists and the best practices, with special focus on patient centered pharmaceutical care framework. This concept, developed and established in USA, due to its sophisticated characteristics has served as the model for Europe and other regions. The parallel concepts have also been developed for pharmacy technicians. However, they are not the subject of this overview. This overview, also presents the different aspects of the professional development and pharmacist's competencies that should be considered in our country, in the near future.
The process of achieving and maintaining the competency in the pharmacy profession and in the entire health care profession indeed, has been the subject of many support programs and initiatives which are to serve the public interest, healthcare professional oversight boards, pharmacy organizations, regulatory agencies, credentialing and governing boards (appendix A).
The basic principles underlying the roles and responsibilities of pharmacists are stated in the Code of Ethics for Pharmacists edited by American Pharmacists Association-APhA. (APhA, 2007) . These principles, based on the moral obligations and qualities, are established in order to serve as a guidance for pharmacists in their relations with patients, health professionals, and society. Hence, defined basic principles include:
1. A pharmacist respects the covenantal relationship between the patient and pharmacist. 2. A pharmacist promotes the good of every patient in a caring, compassionate, and confidential manner. 3. A pharmacist respects the autonomy and dignity of each patient. 4. A pharmacist acts with honesty and integrity in professional relationships. 5. A pharmacist maintains professional competence. 6. A pharmacist respects the values and abilities of colleagues and other health professionals. 7. A pharmacist serves individual, community and societal needs. 8. A pharmacist seeks justice in the distribution of health resources
According to the fifth principle, it is obvious that professional competence is one of the key points in the pharmacy career.
The Institute of Medicine (IOM) identified five core competencies required for all health professionals (including pharmacists) aimed at optimizing patients' outcomes. They are the following: (I) deliver patient-centered care; (II) work as part of an interdisciplinary team; (III) practice evidence-based medicine; (IV) apply quality improvement approaches; and (V) use information technology. These competencies are the base for developing relevant standards and competence statements concerning healthcare professionals. The recommendations targeting oversight organizations include integrating these core competencies into accreditation, and certification processes across the professions. IOM challenges health care oversight agencies (licensing boards and certifying agencies) to abandon reliance on continuing education in favor of a more systematic approach that require each practitioner's competence be assessed, that interventions be targeted to specific deficiencies, and that each care-giver be tested to ensure that the desired competencies have been acquired and incorporated into practice. The employees must demonstrate professional judgment, ethics, attitudes, and values (Greiner and Knebel, 2003) .
Citizen Advocacy Center (CAC) urges to put the subject of continual competence on the agendas of theirs and related organizations' meetings and conferences to generate considerable interest and support. Thus, at CAC Conference held in June, 2000, the National Association of Boards of Pharmacy (NABP) representative stated that:"there has been a philosophical change in the way consumers approach health care practitioners". It appeared that in the past, professionals used to say: "Trust me to be competent because I practice every day". But, at present, patients are saying: "Demonstrate to me that you are competent because my life and well being are in your hands" (CAC, 2001) . Moreover, CAC recommended a five-step framework for assessing and demonstrating continual professional competence: (i) routine periodic assessment, (ii) development of a personal improvement plan, (iii) implementation of the improvement plan documentation (steps for quality improvement) and (iv) demonstration of competence (quality assurance step). The critical first step is routine periodic assessment. It serves as the key to identify knowledge deficiencies requiring correction and to tailor lifelong learning 1 choices according to the needs of individual health care professionals. Assessment also reveals whether a practitioner applies his or her knowledge and skills competently in clinical situations.
In addition, Council on Credentialing in Pharmacy (CCP) adopted the following definition about competence in 2000, as follow: "The ability to perform one's duties accurately, make correct judgments, and interact appropriately with patients and with colleagues. Professional competence is characterized by good problem-solving and decision-making abilities, a strong knowledge base, and the ability to apply knowledge and experience to diverse patient-care situations" (CCP, 2006) .
It is more than clear that the pharmacists intend to take leadership roles in improving the use of medicines, which they cannot accomplish if working do in isolation from the many others professionals involved in the medicines use process (WHO, 2006) .
Tasks and Functions of Pharmacists and Future Vision of Pharmacy Practice
Contemporary pharmacy practice reflects an evolving pattern: from having a primary role in medicine distribution and advising patients to a much broader and teambased clinical role which includes provision of patient centered medicine therapy management, health improvement, and disease prevention services. Thus, the pharmacy practice integrates fields that are directly related to the patient and performed in community pharmacy, ambulatory care clinics, hospitals, long-term care facilities, home-care institutions, and managed-care organizations.
However, other roles of pharmacists are practiced in the pharmaceutical industry, research and development, national agencies, academia, associations, and a number of unique healthcare practices such as drug and poison information centers that are not directly related to patient care.
The Model State Pharmacy Act and Model Rules of the NABP define the practice of pharmacy as follows: The "Practice of Pharmacy" means the interpretation, evaluation, and implementation of Medical Orders; the Dispensing of Prescription Drug Orders; participation in Drug and Device selection; Drug Administration; Drug Regimen Review; the Practice of Telepharmacy within and across state lines; Drug or Drug-related research; the provision of Patient Counseling; the provision of those acts or services necessary to provide Pharmacist Care in all areas of patient care, including Primary Care and Collaborative Pharmacy Practice; and the responsibility for Compounding and Labeling of Drugs and Devices (except Labeling by a Manufacturer, Re-packager, or Distributor of Non-Prescription Drugs and commercially packaged Legend Drugs and Devices), proper and safe storage of Drugs and Devices, and maintenance of required records.
The practice of pharmacy also includes continually optimizing patient safety and quality of services through effective use of emerging technologies and competencybased training (NABP, 2006) .
Following the third Joint Commission of Pharmacy Practitioners (JCPP) -"Pharmacy in the 21 st Century", at the Conference in 1994, a collaborative effort of ten national pharmacy organizations led to the development of the Pharmacist Practice Activity Classification (PPAC), a hierarchical categorization of pharmacist activities (Table  1 ). The PPAC is focused primarily on activities of licensed, practicing pharmacists across the continuum of health care settings. The PPAC also includes activities that are either delegated by pharmacists to technicians or are carried out by automated systems. The PPAC facilitates the compara-ble data among studies, such as: building databases for statistical purposes about pharmacists'; patient-centered activities (to improve patient outcomes); the use of resources and provides a solid foundation to support systems for payment model that can be used for billing. The classification captures a range of activities from a traditional dispensingbased practice towards a higher level of patient care and direct patient care services.
This document classify pharmacy practice activities as follows: the highest level is the Domain or field of activity where four major domains of pharmacist activities have been identified. Within each domain there are more specific Classes of Activities. Within each Class there are Activities or Interventions -labels for sets of specific behaviors that, based on their professional knowledge and clinical judgment, pharmacists engage in as a part of their professional practice to enhance patient care and outcomes. Under many of the activities, one or more Tasks are specified. Some tasks are further divided into distinct Steps. Each entry has a unique alphanumeric identity. It is expected that this design will allow for easy and timely modification of the system (Maine,1998 According to the well known consensus document: "The Future Vision for Pharmacy Practice 2015" that has been officially adopted by the JCPP: "Pharmacists will be the healthcare professionals responsible for providing patient care that ensures optimal medication therapy outcomes." The concept of "optimal medication therapy" implies that the use of medicines occurs within a system that assures the highest possibility of achieving desired clinical, humanistic, and economic outcomes. The "JCPP Vision" further states that: "Pharmacists will benefit society and be essential to the provision of effective health care by ensuring that: (a) medication therapy management is readily available to all patients;(b) desired patient outcomes are more frequently achieved; (c) overuse, underuse, and misuse of medications are minimized; (d) medication-related public health goals are more effectively achieved; and (e) cost effectiveness of medication therapy is optimized" (JCPP, 2004) With the aim of achieving the mission of pharmacy profession and fulfilling these professional activities, a sound pharmacists' education and numerous post-graduate studies and training opportunities have been introduced and made available to pharmacists.
I. Professional competencies addressing pharmacy practice
1. Competency based education -credential needed to prepare for pharmacy practice Miller, graded the competency-based education on four levels: the learner knows the facts (cognition), knows how to apply the facts, shows how (in a controlled environment) and does (behavior, in real situations) (Miller, 1990) . At the beginning, the curricula lead the learner from dependent and directed towards independent, self-directed and lifelong learner. Pharmaceutical education needs to develop content and process of the educational curriculum that is required to prepare students to render pharmaceutical care at the entry points in the health care system.
As concerns the competency based education, accreditation standards and guidelines have been established for the Professional Program in Pharmacy leading to the Doctor of Pharmacy Degree by the Accreditation Council for Pharmacy Education-ACPE (ACPE, 2006) . According to Standard No. 9, the Goal of the Curriculum is: "The college or school's professional degree curriculum must equip the graduates with professional competencies in order to enter the pharmacy practice in any setting and ensure optimal medication therapy outcomes and patient safety, satisfy the educational requirements for obtaining a license as a pharmacist, and meet the requirements for the university degree. The curriculum must provide the graduates with knowledge that meets the criteria of good science; professional skills, attitudes, and values; and the ability to integrate and apply learning to both the present practice of pharmacy and the advancement of the profession. Graduates must be able to identify and implement needed changes in pharmacy practice and health care delivery".
The AACP (American Association of Colleges of Pharmacy) proposed a series of initiatives under the Center for the Advancement of Pharmaceutical Education (CAPE) with the aim of supporting and facilitating the efforts of colleges and schools of pharmacy in the US for transforming their curricula and supporting the education of future practitioners to deliver pharmaceutical care. Important fea- tures of the design of the new curricula were the CAPE Educational Outcomes, which the evolving pharmacy curriculum should pursue. Upon request by 2001-02 AACP Academic Affairs and Professional Affairs Committees, the AACP Board of Directors committed to review and revise the CAPE Educational Outcomes during 2003-04. The result of this revision, CAPE Educational Outcomes 2004 provided a framework that integrated the professionalism, inter-professional practice, ethical attitudes and behaviors, and basic science across three expected educational outcomes: (i) Pharmaceutical Care, (ii) Systems Management, and (iii) Public Health in order to meet the mandate of this mission (AACP, 2004) . Pursuant to this framework, ACPE adopted the CAPE Educational Outcomes with minor modifications. AACP CAPE educational outcomes and Standard No.12 are summarized in Table 2 . It was noted that a periodic review and revision should be conducted in order to ensure the contemporary validity of the educational content and outcomes with emerging sciences and scientific developments and evolving roles of the pharmacists in serving patient and public health needs.
Problem-based curricula have been introduced at universities in a number of countries (Savery, 2006) . These standards are used to assess health professionals' knowledge and skills during in reregistration examinations or during the continual professional development (CPD). In fact, CPD including research and reflecting the outcomes of actions contributes to maintaining the life-long competency to practice. CPD framework will be elaborated in the text below.
Credentials that needs to enter into practice and renew professional knowledge and skills.
NAPB, as an association of state boards of pharmacists, assists its member boards and jurisdictions in developing, implementing, and enforcing uniform standards for the purpose of protecting the public health. NAPB develops diversity of programs such as: examination, licensure, assessment, consumer protection, accreditation and CPE monitor.
One of the NABP examination programs is the North American Pharmacist Licensure Examination (NAPLEX ® ) (Newton, Boyle and Catizone, 2008) . NAPLEX is the principal licensure examination that must be passed by all graduates from an accredited professional degree program in pharmacy in order to obtain licensure and practice as a pharmacist. In this instance, candidates are licensed to practice after having: (I) a degree in pharmacy ap-proved by the board, (II) have completed the minimum number of hours in practice; and (III) have passed the licensing examination.
The NAPLEX assesses the ability of a prospective pharmacist to identify the practice standards for safe and effective pharmacotherapy; optimize therapeutic outcomes in patients; determine safe and accurate methods to prepare and dispense medications; and provide and apply health care information to promote optimal health care. In 1996, the NAPLEX introduced the computer adaptive testing (CAT) model to the professional pharmacy. The CAT NA-PLEX is designed according to a set of specific knowledge areas and practice functions and skills, i.e. the Competency Statements or Competencies published in the Blueprint (NABP, 2006) , Table 3 . The ACPE Standards are some of the reference sources for determining the NAPLEX Blueprint. The Blueprint reflects the knowledge, judgment, and skills to be demonstrated by an entry-level pharmacist to protect the health and welfare of his or her patients.
There is no doubt that AACP CAPE Educational Outcomes 2004, ACPE Standard No.12 Professional Competencies and Outcome Expectations, NAPLEX ® Blueprint and the PPAC are closely related to the five core competencies applicable to all healthcare professionals and recently identified by the IOM.
However, NAPLEX should not be considered as the final examination of the college's or school's curricula. Therefore, in 2005, NABP introduced the Pharmacists Self-Assessment Mechanism (PSAM) (NAPB, 2005) . The PSAM is 100 questions assessment for pharmacists to evaluate their professional practice skills and knowledge. The PSAM Blueprint Competencies are similar to those of NAPLEX. Moreover, the MPJE (Multistate Pharmacy Jurisprudence Examination), combines federal and state-specific questions to test the pharmacy jurisprudence knowledge of prospective pharmacist. It serves as the pharmacy law examination in participating jurisdictions. Graduates from foreign colleges of pharmacy must document that they have education and experience equivalent to their UStrained colleagues. They must also pass the Foreign Pharmacy Graduate Equivalency Examination (FPGEE), the Test of English as a Foreign Language (TOEFL), and the Test of Spoken English (TSE). Once these requirements are met, they receive the Foreign Pharmacy Graduate Examination Committee's (FPGEC) certificate. In addition to the NAPLEX ® and MPJE ® , some US states require a laboratory examination or an oral examination before licensure is conferred. All state boards also require that candidates complete an internship before being licensed. The internship may be completed during the candidate's academic training or after graduation, depending on the state requirements. An internship requirement traditionally requires a pharmacy student to work in a licensed pharmacy under the supervision of a board-registered pharmacist or to complete collegecoordinated clerkships as equivalent to (or as a significant portion of) state-mandated internships. A license to practice Pharmacy as a Pharmacy Intern shall be granted only to those individuals who:(1) are enrolled in a professional degree program of a school or college of pharmacy that has been approved by the Board and satisfactorily progressing toward meeting the requirements for licensure as a Pharmacist; or (2) are graduates of an approved professional degree program of a school or college of Pharmacy or are graduates who have established educational equivalency by obtaining a Foreign Pharmacy Graduate Examination Committee™ (FPGEC ® ) Certificate, who are currently licensed by the Board of Pharmacy for the purpose of obtaining practical experience as a requirement for licensure as a Pharmacist; or (3) are qualified applicants awaiting examination for licensure or meeting Board requirements for re-licensure; or (4) are participating in a residency or fellowship program.
Licensure renewal: licensure renewal is mandatory for pharmacists who wish to continue to practice their profession. All member state boards of pharmacy require that registered pharmacists complete a minimum number of hours or continual education units (CEUs) before they can renew their licenses. Continual education is defined by CCP as: Organized learning experiences and activities in which pharmacists engage after they have completed their entry-level academic education and training. These experiences are designed to promote the continuous development of the skills, attitudes, and knowledge needed to maintain proficiency, provide quality servicer products, respond to patient needs, and keep abreast of change (CCP, 2001) .
More recently (June 2003), ACPE adopted the following definition: Continuing education for the profession of pharmacy is a structured process of education designed or intended to support the continuous development of pharmacists to maintain and enhance their professional competence. Continuing education should promote problemsolving and critical thinking and be applicable to the practice of pharmacy (ACPE, 2003) .
The candidate for licensure renewal may acquire a number of CEUs by attending educational seminars, teleconferences, meetings reading journal articles, completing home study courses or computer-based educational programs (CCP, 2006) .
The hours or CEUs must be earned either through participation in a continuing education (CE) program whose provider has been accredited by the ACPE, or through a program or activity, which has been otherwise approved by the state board. Achievement of a satisfactory score on an assessment that is created by and submitted to the CE provider is generally required as a documentation of completion of a CE program.
The ACPE has established accreditation standards for providers of continuing pharmacy education. The majority of ACPE-approved providers are professional pharmacy organizations, colleges of pharmacy, and pharmaceutical companies. Each program is reviewed every 6 years by the ACPE. ACPE re-evaluates the CE model in pharmacy through a process of identification of the CE requirements of other organizations, exploration of the CE processes and activities of other health professions, domestic and international, including the use of new models, such as CPD. Also, ACPE is exploring the re-engineering of the CE provider accreditation process to make it more efficient and effective, while fostering continuous quality improvement and encouraging innovation (ACPE, 2001).
II. Professional development and enhanced competency of pharmacist
While, academic degrees in the field of pharmacy, state licensure and re-licensure are obligated, mandatory, other credentials (postgraduate degrees, certificates and certification), pharmacists earn to document their specialized or advanced knowledge and skills on voluntary bases. Pharmacy practitioners who have completed programs of various types that are intended to develop and enhance their knowledge and skills or those who have successfully documented a specialized level of knowledge and skills through an assessment process are awarded appropriate qualification. Many different organizations (public and private) are directly involved in assessing pharmacists' knowledge and skills, granting credentials and certificates, and accrediting educational programs and institutions. Post-licensure training programs and credentials are competency-based, developed on the basis of a comprehensive practice analysis in the relevant areas, and offered or accredited by an organization that adhere to the accepted principles and practices to assure quality, integrity, and validity. A pharmacist's credentials are indicators that he or she holds the qualifications needed to practice the profession of pharmacy and is therefore worthy of the trust of patients, of other health care professionals and of the society as a whole (CCP, 2006; Scope of Contep. PP, 2009 ).
The three categories of pharmacist credentials and oversight bodies are illustrated in Figure 1 .
Academic Postgraduate Education and Training
Postgraduate master's (M.S.) programs cover common fields of studies: business administration, clinical pharmacy and public health.
Postgraduate doctor of philosophy (Ph.D.) programs cover common fields of studies: pharmacology, pharmaceutics, pharmaceutical and medicinal chemistry, pharma-Professional competences, credentialing and continuing professional development in the pharmacy profession cotherapeutics, pharmacy practice and social and administrative scie nces.
Residency Training program (Credential acquired: Residency Certificate)
A residency is an organized, directed postgraduate program, accredited by American Society of Health-System Pharmacists (ASHP) independently or in collaboration with other pharmacy organizations in a defined area of pharmacy practice. Residencies usually last 12 months, although certain specialized residencies require additional 12 (or continuous 24) months for completion - Table 4 .
Pharmacy practice residencies -PGY1 (Post Graduate Year one)
Pharmacy practice residencies focus on the development of the resident of professional competence in the delivery of patient care (providing optimum medication therapy outcomes) and practice management activities (managing medication use process). This program provides an environment and structure for accelerating the growth and experience beyond entry-level professional competence through supervised practice under the guidance of model practitioners in "real-world" settings (hospital, community pharmacy, managed care organization, home or long term care practice). Residents are exposed to a wide range of patients with multiple diseases, chronic or acute, and work with a variety of health professionals, thereby advancing their clinical, interpersonal, and leadership skills.
Specialized pharmacy practice residencies PGY2 (Post Graduate Year two)
Specialized pharmacy practice residencies focus on the knowledge, skills, attitudes and abilities to raise the resident ' s level of expertise needed to provide care in a specialized area of pharmacy practice (e.g., critical care, drug information, pharmacotherapy, or oncology). This specialized residency training is an organized, directed, accredited program that builds upon the competencies established in pharmacy practice residencies, after the first year of residency training. The second year of postgraduate residency training involves additional education and pharmacists obtain more in-depth training and experience. In partnership with the APhA for Community Pharmacy, and the Academy of Managed Care Pharmacy (AMCP) for Managed Care, the American Society of Health-System Phar-macists′ Research and Foundation has established residency standards and reviews for programs that include community and managed care pharmacy residencies. The National Association of Chain Drug Stores (NACDS) and National Community Pharmacists Association (NCPA) sup- ported community pharmacy residency programs, including development of the NACDS/NCPA community pharmacy residency guidelines. The Institute for the Advancement of Community Pharmacy, (an organization founded by the NACDS and NCPA), has provided grants to encourage schools of pharmacy and community pharmacies to develop additional community pharmacy residency programs nationwide (Sheaffer, 2004) .
Fellowships (Credential acquired: Fellowship Certificate)
Fellowship is direct, highly individualized postgraduate program that prepares the participant to become an independent researcher in an area of pharmacy practice. Fellowship programs are developed by faculties of pharmacy, academic health centers, universities, pharmaceutical manufacturers and usually last one to two years. ACCP (American College of Clinical Pharmacy) has developed guidelines for organization of clinical fellowships. To improve the consistency in the quantity and quality of the research experience, the ACCP has implemented a process for peer review of pharmacy fellowship training programs. If the specialist qualifications and the training program meet the guidelines based on a review by the ACCP Fellowship Review Committee, they are recognized and the program and specialist are listed on the ACCP Web site (CCP, 2006) . Otherwise, there is no formal accreditation process.
Certificate Programs (Credential earned: Certificate of Completion)
A certificate program is a structured and systematic postgraduate continuing education experience for pharmacists that is smaller in magnitude and shorter in duration than degree programs. Certificate programs are offered by national and state pharmacy organizations and by schools and colleges of pharmacy and other educational groups (CCP, 2006) . The design of certificate programs includes didactic instruction, practice experiences, simulations, and/ or other opportunities for the demonstration of desired professional competencies. Attributes that differentiate certificate program from CE programs are practice experiences, simulations and other activities for demonstration of stated competencies. The length of any particular certificate program is determined by its stated goals, desired professional competencies and outcome measures. This generally requires a minimum of 15 contact hours (1.5 CEUs). Certificate programs are designed to instill, expand, or enhance practice competencies through the systematic acquisition of specified knowledge, skills, attitudes, and behaviors. For example, the APhA offers programs in such areas as asthma, diabetes, immunization delivery, and management of dyslipidemias. The value of these programs depends on individuals' goals or in instances when an employer or regulatory body recognizes the importance of the certificate. Examples are state boards of pharmacy that allow pharmacists to administer vaccines, after they have completed a certificate program in vaccine administration.
Traineeships
In contrast to certificate programs, traineeships allow practicing pharmacists abbreviated clinical training experience through intensive, individualized, structured postgraduate programs (combination of self-study and didac- tic instruction) under supervision of a pharmacist practicing in a given specialty. These programs provide the participants with the knowledge and skills needed to give a high level of care to patients with various chronic diseases and conditions. Traineeships are generally of longer duration (about five days) and involve smaller groups of trainees than certificate programs. Examples of such programs are anticoagulation management, critical care pharmacy, and diabetes management. These programs are commonly offered through the foundations of professional organizations such as the American College of Apothecaries, (ACA), American Society of Consultant Pharmacists (ASCP), and ASHP and are often supported by grants from the pharmaceutical industry.
Certification
Certification is "voluntary process by which a nongovernmental agency or an association grants recognition to an individual who has met certain predetermined qualifications specified by that organization". The credentials are granted to pharmacists and other health professionals who have demonstrated a level of competence in a well-defined, specific and relatively narrow area of practice. Certification is granted on the basis of successful completion of rigorously developed eligibility criteria that include a written examination and, in some cases, an experiential component. Also, certification usually requires initial assessment and periodic reassessments of the individual′s knowledge, skills and/or experience. The certification process is undertaken and overseen by the Board of Pharmaceutical Specialties (BPS), the Commission on Certification in Geriatric Pharmacy (CCGP), and the National Institute for Standards in Pharmacist Credentialing (NISPC).
I. Specialty certification (Credential acquired: Certification in area of practice).
Pharmacists are certificated in five specialties by the BPS: (1) nuclear pharmacy; (2) nutrition support pharmacy; (3) oncology pharmacy; (4) pharmacotherapy and (5) psychiatric pharmacy. Later on, in 1997, BPS introduced the designation of "Added Qualifications" to denote that an individual has demonstrated an enhanced level of training and experience in one segment of a BPS-recognized Professional competences, credentialing and continuing professional development in the pharmacy profession specialty. Infectious Diseases and Cardiology are the two added qualifications for the pharmacotherapy specialty currently recognized by BPS. Pharmacists who wish to retain BPS certification must be recertified every seven years.
II. Non-specialty certification
For example, to become certified by CCGP, candidates are expected to be knowledgeable about principles of geriatric pharmacotherapy and the provision of pharmaceutical care to the elderly. Pharmacists who meet CCGP's requirements are entitled to use the designation Certified Geriatric Pharmacist, or CGP. Pharmacists who wish to retain their CGP credential must recertify every five years by successfully completing a written examination.
III. Disease management certification
NISPC offers certification in the management of diabetes, asthma, dyslipidemia, and anticoagulation therapy. To be certified by the NISPC, a pharmacist must pass an examination with questions that are specific to the specialty area, developed by experts, and designed to address four different areas of competency expected by all pharmacists who provide disease state management services to patients. There are no practice experiences or clinical training requirements in the specialty area. After passing the exam, pharmacists may use the designation of certified disease manager (CDM). Recertification is required every 3 years and is based on completion of 30 hours of CE in the specific disease state.
Also, multidisciplinary certification programs are available to professionals from many health disciplines, including pharmacists. Areas in which such certification is available include diabetes education, anticoagulation therapy, pain management, and asthma education. Table  5 shows post-licensure certifications and where they typically apply to pharmacists in narrowly focused and/or advanced areas of practice.
Relationship between the scope of a pharmacist's practice and credentials and post-licensure education and training
Figures bellow (Figures 2, 3 and 4 ) present a framework for credentialing in pharmacy and summarize the elements (CCP, 2009). The framework attempts to illustrate:
(1) how a pharmacist's career may evolve or progress after completion of initial professional education, licensure, and entry to practice; (2) al Outcome #1. However, Outcomes #2 and #3 are not included in the schematic presentations (CCP, 2009) .
The surface A describes the practice of the community and hospital pharmacists. Surfaces B, C, or D reflects pharmacists professional development in a specific way. For example, pharmacists who choose to narrow their patient or practice focus (e.g. in diabetes or geriatrics) will move to surface B; pharmacists who elect choose to work with a broad base of patients and diseases, but also wish to substantially advance their level of knowledge, skills, and experience will move to surface C. An example of a pharmacist in this quadrant would be a pharmacotherapy specialist. Pharmacists in surface D have both narrowed their patient/practice focus and substantially advanced their knowledge and skills. An example of an Advanced Focused Practitioner would be a Board Certified Oncology Pharmacist (BCOP), one of the recognized specialty credentials in the pharmacy profession. Figure 3 illustrates the range of post-licensure education and training activities pharmacists engage in to maintain their professional competencies and to support their continuing professional development.
Pharmacy practice residencies-(PGY1) provide training for generalists in hospitals, health systems, managed care, or community settings; hence their illustration is in Quadrant A in Figure 3 . Specialized pharmacy practice res-idencies (-PGY2) residencies provide advanced training in a focused area of patient care. Traineeships, on the other hand, are more focused and would typically be undertaken by pharmacists with a narrower patient/practice focus (Quadrant B). Certificate Programs, which focus on the development of professional skills and their application in practice, would typically be undertaken by pharmacists in Quadrants A and B.
III. Continuing Professional Development (CPD)
The Institute of Personnel and Development (IPD, UK) launched an early definition of CPD in October 1997: CPD is systematic, ongoing, self-directed learning. It is an approach or process, which should be a normal part of how you plan and manage your whole working life. Of note, the definition of CPD adopted by the National Health Service (NHS) in Great Britain, in 1999, makes reference to patients and healthcare outcomes:
CPD is a process of lifelong learning for all individuals and teams of individuals which meets the needs of patients and delivers the health outcomes and healthcare priorities of the NHS and which enables professionals to expand to fulfill their potentia .
In 2002, the concept of CPD was described by FIP as: The responsibility of individual pharmacists for systematic maintenance, development and broadening of knowledge, skills and attitudes, to ensure continuing competence as a professional, throughout their careers (FIP, 2002) .
The same year, at a conference on lifelong learning, the following definition was offered:
Postgraduate professional education involving a cycle by which individual practitioners assess their learning needs, create a personal learning plan, implement the plan, and evaluate the effectiveness of the education intervention as it applies to their pharmacy practice (Hanson, 2002) .
ACPE recent statement regarding CPD is that the CPD model provides the opportunity for quality improvement of the current system of continuing education, by building on the existing strong foundation of quality-assured, accredited continuing education for pharmacists (ACPE, 2003) . The JCPP supports the concept of strong commitment to develop and maintain standards and programs to assure the public, governmental agencies, major employers and other influential organizations that pharmacists would maintain appropriate competencies throughout their careers.
The NAPB in NABP RESOLUTION NO.99-7-03 TI-TLE (NABP, 2003) : Continuing Pharmacy Practice Competency resolved that NABP endorse and encourage structured programs of continuing professional development. Hence, NABP encourage colleges, faculties, and schools of pharmacy and boards to collaborate on providing seminars to further pharmacist continuing professional development; the boards of pharmacy encourage, endorse, and support the efforts of NABP, the ACPE, and the AACP to instill and perpetuate the concepts of continuing professional development in students and pharmacists.
The AACP supports the concept of CPD, so AACP work actively with ACPE and other pharmacy organizations in exploring methods for facilitating its use within pharmacy (AACP, 2003) .
All these definitions and statements clearly indicate that pharmacists have an ethical obligation and responsibility for their own lifelong learning, and the maintenance of the knowledge, skills, attitudes and abilities necessary to deliver professional services in line with accepted, contemporary professional standards and public expectations.
Since the system of mandatory CE has shown that it does not provide a satisfactory degree of assurance that pharmacists are maintaining the level of competence adequate to meet public needs and expectations, the framework of CPD has been evolved as an agenda for lifelong learning.
However, CPD does not replace CE, but quality-assured CE is an essential component of CPD.
The need for CPD can be shortly summarized as follows:
• To ensure that pharmacists maintain (at an appropriate level) their knowledge, skills and competence to practice throughout their careers in their own specific (or current) area of practice; • To improve the pharmacist's personal perfor-mance (i.e., develop knowledge and skills); • To enhance the pharmacist's career progression Besides, CPD is based on principles as follows (Picton and Brackley, 1999) • CPD is a systematic, ongoing cyclical process of self-directed learning; • It includes everything that practitioners learn, which enables them to be more effective as professionals; • CPD includes the entire scope of the practitioner's practice, and may include activities both within and outside the usual work setting; • CPD is a partnership between the practitioner and his or her organization, meeting the needs of both; • The practitioner is responsible for his/her own professional development. The organization has a responsibility to help the practitioner meet the development needs that relate to performance in his/her current job
When considered together with the NHS definition given earlier, three important features of CPD are clear: CPD is practitioner-centered and self-directed; CPD is designed to be practice-related; CPD is outcomes-oriented in terms of maintaining competence, the professional development of the practitioner, meeting individual and organizational goals, and achieving improved patient outcomes. CPD has been described using four-stage and fivestage cycles ( Figure 5 ). Reflect: referred to as "self-appraisal" or "assessment," this stage entails the pharmacist reflecting on personal and organization needs and goals for professional development, and self-assessing his/her knowledge, skills and competence. Reflection is important to learning; it has been defined as the complex and deliberate process of thinking about and interpreting an experience in order to learn from it. (Boud, Keogh and Walker,1985) .
Plan: involves the design of a personal development plan (PDP). The plan includes all the activities that will address the identified learning and development needs and goals. The outcomes should be linked to one or more spe-cific professional competencies (ACPE, 2003) . The plan could include structured programs (such as accredited CE), as well as a diverse range of informal learning activities, many of which will be work-based or work related (Figure 6) . Figure 6 . The PDP is recorded in the personal portfolio.
Each pharmacist's situation is unique, so no two sets of learning needs and personal plans will be the same.
Act: putting the plan into action is the next well known stage.
Evaluation: can be carried out by the individual practitioner, by the practitioner's peers, or by the practitioner's supervisor or manager. In some CPD models (for example, in the UK), the portfolio is subject to review by the regulatory body. For example, in Ontario, Canada there is the opportunity for small-group peer review of the learning portfolio, and also for direct assessment of knowledge and skills. Some form of third-party review or evaluation of the portfolio would appear to be valuable, not only to provide feedback to the pharmacist, but also as a means to identify those that may be experiencing difficulty in one or more aspects of CPD, and in need of assistance or remediation, and to protect society from the few practitioners who otherwise would not self-assess and correct deficiencies. Feedback from third parties should be given in a constructive and non-threatening way, with the primary objective being to help the individual move forward in his/her professional development.
Record: central to the CPD cycle is the practitioner's personal portfolio, which becomes a comprehensive record, like a professional diary or transcript covering all the stages. The portfolio, which can be electronic or paperbased, should be readily accessible, and simple to use. Ideally, a standardized format should be adopted to facilitate training, data entry and, where applicable, portfolio evaluation. In CPD portfolios, pharmacists record all relevant learning experiences (accredited-CE or informal workbased) or work related activities. In time, the pharmacist's portfolio will develop into a comprehensive record of education and practice with multiple possible applications.
CPD is based on the above mentioned principles and adopts educational strategies that have proven to be effective. It potentially offers a quality improvement to the current systems for pharmacist CE. While an appropriate, competency-based education can prepare a pharmacist to enter practice, no professional program can provide or develop all the aspects of the knowledge, skills, attitudes and abilities that a pharmacist will ever need. These require a combination of an appropriate pre-service educational foundation, in-service training, hands-on work experience, and lifelong learning. For professionals, there is no doubt that education is a continuum. As acknowledged, the educational strategies, and the competency and outcomes based approach that are successfully utilized for pre-service training must be maintained throughout the practitioner's career. For all above mentioned, the state boards of pharmacy are requested, and expected, to protect the public by ensuring, through regulation, that licensed pharmacists are competent to deliver pharmacy services, as professionals.
Conclusion
As anticipated, due to the dynamic and intensely developing healthcare environment in the past several years, the pharmacist's role has dramatically changed from that of conventional compounder and dispenser to one of "drug therapy manager". The latter comprehensive role of the pharmacist involves spectrum of new responsibilities and best practice services to ensure that wherever the drug therapy is concerned, the best quality products to be selected, procured, stored, distributed, dispensed and properly administered in a manner so as to contribute to the health of patients with the risk reduced to the minimum for the patient. Now, the scope of pharmacy practice is more focused on patientcentered care, with all the cognitive functions of counseling, providing drug information and specific issues related to the managing and monitoring drug therapy. Pharmacists need to maintain their professional competence throughout their careers in order to provide safe, effective and quality professional services to patients and achieve the most positive patient outcomes possible. Schools of pharmacy prepare their graduates to acquire the necessary and rational competencies to enter practice, but the ongoing professional program can also provide or develop knowledge, skills, attitudes and abilities that a pharmacist will need in practice. Only a combination of an appropriate educational foundation, in-service training, hands-on work experience, lifelong learning, training and ongoing licensure, certification and evaluation of competencies will assure professional competence. Particularly noteworthy aspect about continuing professional development is that it can further engage pharmacists as adult learners, and enhance the overall effectiveness and outcomes of continuing education. Creating models for professional development provides the opportunity for quality improvement of the current system of continuing education, building on the existing strong foundation of qualityassured, accredited continuing education for pharmacists.
Health care systems, more stringent regulations and the existing oversight programs of licensure and certification agencies have the obligation to assure the public of the safety and quality of health care, including the pharmaceutical care. It is of paramount importance and great responsibility of each individual pharmacist to determine whether a higher standard is required in any area relating to their individual professional practice. And, finally, pharmacists as health care professionals have to commit themselves to lifelong learning, in order to remain current and proficient as the science base for medicine continues to evolve and become more complex.
There is no doubt, that the models of professional competences, credentialing and continuing professional development in pharmacy exist in many worldwide countries intending to promote consistency and uniformity in the delivery of professional services. However, the US model deserves special attention owing to its comprehensive approach and advanced practical solutions.
